Capricor Therapeutics CAPR
NASDAQ CAPR
$9.00 -0.47 (-4.96%)
As of: Oct 1, 2026 · 2:30 PM EDT

Capricor Therapeutics (CAPR) Non Operating Income (2010 - 2026)

Updated

Capricor Therapeutics' Non Operating Income was $2.21 million in Q2 2026, up 22.4% from $1.81 million a year earlier but down 21.8% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Non Operating Income (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Capricor Therapeutics' Non Operating Income was $5.75 million through Jun 30, 2026, up 67.3% year-over-year; for FY2025, it came in at $3.1 million, up 47.8% from FY2024.

  • Non Operating Income has now increased for three consecutive years, with a five-year compound annual growth rate of 148.1% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $2.1 million in FY2024 (+17.2%), $1.79 million in FY2023 (+164.1%), $677,851 in FY2022 (-26.0%) and $915,922 in FY2021.
  • Quarterly Non Operating Income has moved between -$1.01 million (Q4 2025) and $2.83 million (Q1 2026) over five years.
  • Compared with a year earlier, Non Operating Income was higher in six of the last seven quarters, with growth averaging 131.1%.
  • The best year-over-year quarter for Non Operating Income over five years was Q1 2026 (growth of 378.8%); the worst was Q3 2022 (a decline of 72.1%).
  • Per Business Quant data, CAPR's Non Operating Income in the three quarters before Q2 2026 was $2.83 million (Q1 2026), -$1.01 million (Q4 2025) and $1.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - 2.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.21 Mn
Mar 31, 2026 2.83 Mn
Dec 31, 2025 -1.01 Mn
Sep 30, 2025 1.71 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 591,354.00
Dec 31, 2024 581,238.00
Sep 30, 2024 453,152.00
Jun 30, 2024 591,437.00
Mar 31, 2024 471,829.00
Dec 31, 2023 519,203.00
Sep 30, 2023 473,992.00
Jun 30, 2023 380,680.00
Mar 31, 2023 416,442.00
Dec 31, 2022 345,433.00
Sep 30, 2022 106,635.00
Jun 30, 2022 212,343.00
Mar 31, 2022 13,440.00
Dec 31, 2021 189,118.00
Sep 30, 2021 382,738.00
API Access

Capricor Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CAPR&period=max&api_key=YOUR_API_KEY